Search

Your search keyword '"Dirks, P. B."' showing total 135 results

Search Constraints

Start Over You searched for: Author "Dirks, P. B." Remove constraint Author: "Dirks, P. B."
135 results on '"Dirks, P. B."'

Search Results

1. Single-cell atlas of the human brain vasculature across development, adulthood and disease

3. A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma

4. macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma

6. Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma

7. Roadmap for the Emerging Field of Cancer Neuroscience

9. Two-Stage Testing Reduces Student-Perceived Exam Anxiety in Introductory Chemistry

10. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

14. Berkeley's New Approach to Global Engagement: Early and Current Efforts to Become More International. Research & Occasional Paper Series: CSHE.12.15

15. The Liberal Arts and the University: Tracing the Origins and Structure of Undergraduate Education in the US and at the University of California. Research & Occasional Paper Series: CSHE.7.15

17. Intertumoral Heterogeneity within Medulloblastoma Subgroups

18. Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity

19. BERKELEY'S NEW APPROACH TO GLOBAL ENGAGEMENT: EARLY & CURRENT EFFORTS TO BECOME MORE INTERNATIONAL

20. The white matter is a pro-differentiative niche for glioblastoma

21. PRMT5 inhibition disrupts splicing and stemness in glioblastoma

23. Stalled developmental programs at the root of pediatric brain tumors

24. GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer

25. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

28. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells

29. Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors

30. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity

31. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

34. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

35. Protocol for the derivation of primary cancer stem cell lines from human ependymal tumors

47. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

48. Scholars, Spies, and Global Studies

50. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study

Catalog

Books, media, physical & digital resources